Search

Takeda Pharmaceutical Co Ltd ADR

Cerrado

SectorSanidad

18.18 0.22

Resumen

Variación precio

24h

Actual

Mínimo

18.14

Máximo

18.18

Métricas clave

By Trading Economics

Ingresos

138B

113B

Ventas

105B

1.2T

P/B

Media del Sector

42.622

57.371

BPA

0.48

Rentabilidad por dividendo

3.5

Margen de beneficios

9.279

Empleados

47,029

EBITDA

180B

337B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+75.41% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.50%

2.23%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-192M

56B

Apertura anterior

17.96

Cierre anterior

18.18

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

328 / 340 Clasificación en Healthcare

Takeda Pharmaceutical Co Ltd ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 ago 2026, 21:42 UTC

News
Correlated Moves

Ethereum is gaining amid positive market sentiment from Canada’s investment announcement, bolstered by declining interest rates. It remains above its 20-day moving average.

22 ago 2026, 23:11 UTC

News

Ethereum is lower today, continuing a decline since Friday's close. Earlier, the asset reached a session low before recovering slightly.

22 ago 2026, 23:11 UTC

News

Ethereum is lower during Saturday's session, reflecting a significant drop since Friday's close. The asset reached a session low earlier today.

22 ago 2026, 00:06 UTC

News

Applied Optoelectronics Inc shares lower in after-market hours following an announcement of a $600 million equity distribution agreement to sell shares.

22 ago 2026, 00:02 UTC

Social Media
News

Sigma Lithium resumes full operations under a new agreement in Brazil, targeting 240,000 tonnes of lithium oxide concentrate next year. Shares are higher in after-hours trading.

22 ago 2026, 00:02 UTC

Correlated Moves
News
Social Media

Coinbase Global Inc is rising in after-market trading, supported by the broader market's gains and Bitcoin's recent price increase toward $250.

22 ago 2026, 00:01 UTC

News

Intuit Inc. shares are lower in after-market trading following a class action lawsuit alleging the company concealed competitive pressures from generative artificial intelligence.

22 ago 2026, 00:01 UTC

News

Texas Pacific Land Corp shares increased in after-market trading. The company has a market capitalization of $26.49 billion and an annualized return of 54.67%.

22 ago 2026, 00:01 UTC

News

Alaska Air Group shares are higher in after-market trading, reflecting broader market gains following a rebound from a recent yield-driven selloff.

21 ago 2026, 23:51 UTC

News

Enova International's subsidiary issued $300.89 million in notes, contributing to positive sentiment. The stock is higher in after-market trading, despite recent volatility.

21 ago 2026, 23:46 UTC

News

Home Depot expands roles for three executives, awarding $500,000 in stock grants. Shares were roughly flat during after-market hours following the announcement.

21 ago 2026, 23:41 UTC

News
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, bolstered by gains from UnitedHealth Group and Merck, despite broader market declines.

21 ago 2026, 23:36 UTC

News

Coty Inc reported a fourth-quarter revenue beat but issued weak guidance, resulting in shares trading lower in after-market hours.

21 ago 2026, 23:31 UTC

Correlated Moves
News

Ethereum's price reached $2,371 today, driven by anticipation of Pepeto's Binance listing and Bitcoin's rally past $79,000, boosting market sentiment.

21 ago 2026, 23:26 UTC

Correlated Moves
News

Citigroup Inc shares are lower during after-market hours, reflecting a slight decline amid broader market trends influenced by geopolitical tensions and bargain hunting.

21 ago 2026, 23:21 UTC

Correlated Moves
News
Social Media

Coinbase Global Inc is rising in after-market trading, supported by Bitcoin's significant gain. The company also launched a feature for immediate token access.

21 ago 2026, 23:06 UTC

News

Verizon Communications is deploying resources in response to a potential tropical storm in Hawaii, contributing to lower shares after Friday's close.

21 ago 2026, 23:06 UTC

Correlated Moves
News

KKR & Co Inc reported a net asset value of $8.49 billion as of July 31, contributing to positive sentiment in after-market trading.

21 ago 2026, 23:01 UTC

Social Media
News

Applied Optoelectronics Inc. plans to sell up to $600 million in shares, contributing to a decline in after-market trading amid dilution concerns.

21 ago 2026, 23:01 UTC

News

Hess Midstream LP shares are advancing in after-market trading following a dividend increase and improved free cash flow, despite lower EBITDA and net income.

21 ago 2026, 23:01 UTC

News

Texas Pacific Land Corp shares are higher in after-hours trading, with a market capitalization of $26.49 billion reflecting strong long-term performance.

21 ago 2026, 23:01 UTC

News
Social Media

Sigma Lithium Corp resumes full operations under a new agreement in Brazil, targeting 240,000 tonnes of lithium oxide concentrate. Shares are advancing in after-market trading.

21 ago 2026, 23:01 UTC

News

Spectrum Brands Holdings Inc shares are higher in after-market trading. The company expects low-single-digit revenue growth for fiscal year 2026 amid ongoing cost pressures.

21 ago 2026, 22:01 UTC

News

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

21 ago 2026, 20:07 UTC

News
Social Media

Microsoft shares are higher, supported by bullish options activity and a reaffirmed AAA rating from Moody's. The company is part of a $615 billion AI investment group.

21 ago 2026, 20:07 UTC

Social Media
News

Palantir Technologies shares are higher today amid increased options trading and positive sentiment, with Deutsche Bank reiterating a $200 price target.

21 ago 2026, 20:07 UTC

News

Aflac shares are lower today as Japan Post sold 12,700 shares, contributing to negative sentiment amid broader market declines since Thursday's close.

21 ago 2026, 20:07 UTC

News

United Parcel Service shares are trading lower as Zacks cuts Q3 EPS estimate to $1.60. Susquehanna raises target price to $120, maintaining a neutral rating.

21 ago 2026, 20:07 UTC

News

Barclays maintains an Overweight rating on Hims & Hers Health, lowering its price target to $35. Shares are trading higher amid positive market sentiment.

21 ago 2026, 20:07 UTC

News
Correlated Moves

The USD/SEK is trading lower today, continuing a decline since Thursday's close. Earlier in the session, the dollar rebounded from a session low.

Comparación entre iguales

Cambio de precio

Takeda Pharmaceutical Co Ltd ADR previsión

Precio Objetivo

By TipRanks

75.41% repunte

Estimación a 12 Meses

Media 31.89 USD  75.41%

Máximo 42.772 USD

Mínimo 21 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Takeda Pharmaceutical Co Ltd ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.